BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34548197)

  • 1. Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunction.
    Paraskeva MA; Borg BM; Paul E; Fuller J; Westall GP; Snell GI
    J Heart Lung Transplant; 2021 Dec; 40(12):1649-1657. PubMed ID: 34548197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline lung allograft dysfunction is associated with impaired survival after double-lung transplantation.
    Liu J; Jackson K; Weinkauf J; Kapasi A; Hirji A; Meyer S; Mullen J; Nagendran J; Lien D; Halloran K
    J Heart Lung Transplant; 2018 Jul; 37(7):895-902. PubMed ID: 29602706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung clearance index is sensitive to small airway disease in pediatric lung transplant recipients.
    Kao JE; Zirbes JM; Conrad CK; Milla CE
    J Heart Lung Transplant; 2017 Sep; 36(9):980-984. PubMed ID: 28651906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation.
    Tague LK; Bedair B; Witt C; Byers DE; Vazquez-Guillamet R; Kulkarni H; Alexander-Brett J; Nava R; Puri V; Kreisel D; Trulock EP; Gelman A; Hachem RR
    J Heart Lung Transplant; 2021 Oct; 40(10):1212-1222. PubMed ID: 34353713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of Best Spirometry in the First Year After Bilateral Lung Transplantation: Association With 3-Year Outcomes.
    Mohanka MR; Kanade R; Garcia H; Mahan L; Bollineni S; Mullins J; Joerns J; Kaza V; Torres F; Zhang S; Banga A
    Transplantation; 2020 Aug; 104(8):1712-1719. PubMed ID: 32732851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast in chronic lung allograft dysfunction after lung transplantation.
    Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
    J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
    Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
    J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
    Todd JL; Jain R; Pavlisko EN; Finlen Copeland CA; Reynolds JM; Snyder LD; Palmer SM
    Am J Respir Crit Care Med; 2014 Jan; 189(2):159-66. PubMed ID: 24325429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
    Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
    J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant Opioid Use and Survival After Lung Transplantation.
    Vahidy S; Li D; Hirji A; Kapasi A; Weinkauf J; Laing B; Lien D; Halloran K
    Transplantation; 2020 Aug; 104(8):1720-1725. PubMed ID: 32732852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of human leukocyte antigen mismatch on lung transplant outcome.
    Yamada Y; Langner T; Inci I; Benden C; Schuurmans M; Weder W; Jungraithmayr W
    Interact Cardiovasc Thorac Surg; 2018 May; 26(5):859-864. PubMed ID: 29300898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
    Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
    J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival.
    Gallagher HM; Sarwar G; Tse T; Sladden TM; Hii E; Yerkovich ST; Hopkins PM; Chambers DC
    J Heart Lung Transplant; 2015 Nov; 34(11):1442-8. PubMed ID: 26186804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and computed tomographic evolution and survival of restrictive allograft syndrome after lung transplantation.
    Verleden SE; de Jong PA; Ruttens D; Vandermeulen E; van Raemdonck DE; Verschakelen J; Vanaudenaerde BM; Verleden GM; Vos R
    J Heart Lung Transplant; 2014 Mar; 33(3):270-7. PubMed ID: 24461432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase-resolved Functional Lung (PREFUL) MRI-derived Ventilation and Perfusion Parameters Predict Future Lung Transplant Loss.
    Vogel-Claussen J; Kaireit TF; Voskrebenzev A; Klimeš F; Glandorf J; Behrendt L; Gutberlet M; Korz C; Speth M; Welte T; Wacker F; Gottlieb J
    Radiology; 2023 May; 307(4):e221958. PubMed ID: 37070996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.